1. Insights /

News

BCLP Advises Alticor in Sale of Metagenics to Gryphon

BCLP Advises Alticor in Sale of Metagenics to Gryphon

Nov 23, 2021
Download PDFDownload PDF
Print
Share

International law firm BCLP has advised Alticor in its sale of Metagenics, a leading global nutritional supplement company, to Gryphon Investors, a private equity firm focused on profitability growing and competitively enhancing middle-market companies in partnership with experienced management.

The value of this transaction, which closed Nov. 1, remains confidential.

Alticor was advised by a BCLP cross-practice deal team from offices in the US and Paris, led by Partner Bob Newmark (Corporate Transactions). Others of key support included Seth Frederiksen (Corporate Transactions), Caitlin Hartsell (Corporate Transactions), Danielle Hennessey (Corporate Transactions) and Zack Carpenter (Corporate Transactions), Becky Nelson (Antitrust), Danielle Mangogna (Antitrust), Jessica Edwards (Tax), Amy de La Lama (Data Privacy), Bart Wall (Finance Transactions), Adam Braun (EBEC).

Read the full press release issued by Gryphon Investors on this transaction >

Related Practice Areas

Corporate 

Antitrust 

Tax & Private Client 

M&A & Corporate Finance 

  • Corporate

  • Antitrust

  • Tax & Private Client

  • M&A & Corporate Finance

Meet The Team

View All Related Professionals 

This material is not comprehensive, is for informational purposes only, and is not legal advice. Your use or receipt of this material does not create an attorney-client relationship between us. If you require legal advice, you should consult an attorney regarding your particular circumstances. The choice of a lawyer is an important decision and should not be based solely upon advertisements. This material may be “Attorney Advertising” under the ethics and professional rules of certain jurisdictions. For advertising purposes, St. Louis, Missouri, is designated BCLP’s principal office and Kathrine Dixon (kathrine.dixon@bclplaw.com) as the responsible attorney.